ACCESS Newswire4d agobearish
Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 StudyNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
106last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Clinical Trials Arena90d agoneutral
FDA approval of mFLUSIVA highlights Moderna’s position in mRNA marketThe Wall Street Journal95d agoneutral
FDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Review